Form 4 for ABBV AbbVie
Accepted 2026-08-18 17:00:16 ET · period of report 2026-08-14 · accession 0001762951-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-18 17:00 | 2026-08-14 | ABBV | Donoghoe Nicholas | EVP, CHIEF BUS, STRAT Off | M - OptEx | $79.02 | +32.7K | 107.1K | +44% | +$2.58M |
| D | 2026-08-18 17:00 | 2026-08-14 | ABBV | Donoghoe Nicholas | EVP, CHIEF BUS, STRAT Off | S - Sale+OE | $250.00 | -32.7K | 74.4K | -31% | -$8.18M |
| D | 2026-08-18 17:00 | 2026-08-14 | ABBV | Donoghoe Nicholas | EVP, CHIEF BUS, STRAT Off | M - OptEx | $0.00 | -32.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2026-08-14 | M | A | 32,710 | $79.02 | 107,140 | D | — | — | |
| 2 | Common | Common Stock, $0.01 par value | 2026-08-14 | S | D | 32,710 | $250.00 | 74,430 | D | — | — | |
| 3 | Derivative | Option (Right to buy) | 2026-08-14 | M | D | 32,710 | $0.00 | 0 | D | $79.02 · — to 2029-02-20 | 32,710 Common Stock | (F1) Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable in annual increments of 10,904 on February 21, 2020, 10,903 on February 21, 2021, and 10,903 on February 21, 2022. |